基本信息 产品详情 公司简介 推荐产品
网站主页 RECOMBINANT HUMAN/小鼠FIBROBLAST GROWTH FACTOR 8B/FGF-8B GMP FGF-8b蛋白
  • GMP级别重组人FGF-8b蛋白
  • GMP级别重组人FGF-8b蛋白
  • GMP级别重组人FGF-8b蛋白

1/3

GMP级别重组人FGF-8b蛋白

FGF-8b
询价 100ug 起订
500ug 起订
1000ug 起订
北京 更新日期:2025-12-30

北京百普赛斯生物科技股份有限公司

VIP3年
联系人:赵先生
手机:13121935750 拨打
邮箱:jiaxin.zhao@acrobiosystems.com

产品详情:

中文名称:
GMP FGF-8b蛋白
英文名称:
FGF-8b
品牌:
百普赛斯
产地:
北京
保存条件:
-20°C to -70°C
纯度规格:
99.9%
产品类别:
重组蛋白
货号:
FGF-8b
用途范围:
科研
规格:
100ug
是否进口:

GMP Human FGF-8b Protein

优势特色(Features

Designed under ISO 9001:2015 and ISO 13485:2016

Manufactured and QC tested under a GMP compliance factory

FDA DMF filed

Animal-Free materials

Beta-lactam materials free

Batch-to-batch consistency

Stringent quality control tests

No animal derived peptone and lactose used in production process

表达区间及表达系统(Source

GMP Human FGF-8b Protein (GMP-FGBH16) is expressed from E. coli cells. It contains AA Gln 23 - Arg 215 (Accession # P55075-3).

蛋白结构(Molecular Characterization

1.jpg

This protein carries no "tag".

The protein has a calculated MW of 22.5 kDa. The protein migrates as 25 kDa±3 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE).

N端测序(N-terminal Sequence Analysis

Met-Gln-Val-Thr-Val-Gln-Ser-Ser-Pro-Asn-Phe-Thr-Gln-His-Val (Routinely tested).

内毒素(Endotoxin

Less than 10 EU/mg by the LAL method / rFC method.

宿主蛋白残留(Host Cell Protein

0.5 ng/µg of protein tested by ELISA.

宿主核酸残留(Host Cell DNA

0.02 ng/μg of protein tested by qPCR.

无菌(Sterility

The sterility testing was performed by membrane filtration method described in USP<71>and Ph. Eur. 2.6.1.

支原体(Mycoplasma

Negative.

纯度(Purity

>95% as determined by SDS-PAGE.

制剂(Formulation

Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with protectants.

Contact us for customized product form or formulation.

运输(Shipping

This product is supplied and shipped with blue ice, please inquire the shipping cost.

存储(Storage

Upon receipt, store it immediately at -20°C or lower for long term storage.

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:

-20°C to -70°C for 5 years in lyophilized state;

-70°C for 12 months under sterile conditions after reconstitution.

2.jpg

3.jpg

背景介绍

FGF-8 is a member of the fibroblast growth factor family that was originally discovered as a growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cells (1-3). Alternate splicing of mouse FGF-8 mR generates eight secreted isoforms, designated a-h, but only FGF-8a, b, e and f exist in humans (4). FGF-8 contains a 22 amino acid (aa) signal sequence, an Nterminal domain that varies according to the isoform (30 aa for FGF-8b; 20 aa for the shortest, FGF-8a), a 125 aa FGF domain and a 37 aa prolinerich Cterminal sequence. The FGF domain of FGF-8 shares the most aa identity with FGF17 (75%) and FGF-18 (67%), and the three form an FGF subfamily (2). Mouse FGF-8b shares 100% aa identity with human FGF-8b. FGF-8 is widely expressed during embryogenesis, and mediates epithelial-mesenchymal transitions. It plays an organizing and inducing role during gastrulation, and regulates patterning of the midbrain/hindbrain, eye, ear, limbs and heart in the embryo (2, 5 - 8). The isoforms may play different roles in development. FGF-8b shows the strongest receptor affinity and oncogenic transforming capacity although FGF-8a and FGF-8e are also transforming and have been found in human prostate, breast or ovarian tumors (1, 5, 9-12). FGF-8 shows limited expression in the normal adult, but low levels are found in the reproductive and genitourinary tract, peripheral leukocytes and bone marrow hematopoietic cells (3, 9, 13).

ACRO GMP产品制造规范

ACROBiosystems GMP级产品是在质量管理体系下生产的,并符合相关指南:

Ph. Eur General Chapter 5.2.12 Raw materials of biological origin for the production of cell-based and gene therapy medicinal products; USP<92>Growth Factors and Cytokines Used in Cell Therapy Manufacturing; USP<1043>Ancillary Materials for Cell, Gene, and Tissue-Engineered Products; ISO/TS 20399-1:2018, Biotechnology - Ancillary Materials Present During the Production of Cellular Therapeutic Products.

ACROBiosystems质量管理体系内容:

1. 根据ISO 9001:2015ISO 13485:2016进行设计,在GMP工厂进行制造和QC检测

2. 无动物成分

3. QA从批准的供应商处采购的材料

4. ISO 5洁净室和自动灌装设备

5. 人员合格

6. 质量保证审核和批准质量相关文件

7. 全批量生产和控制记录

8. 设备维护和校准

9. 分析程序的验证

10. 进行的稳定性研究

11. 全面的法规支持文件

ACROBiosystems对我们的GMP级产品提供严格的质量控制测试(经过充分验证的设备、工艺和测试方法),以确保它们在纯度、安全性、活性和批间稳定性方面符合严格的标准,每个批量QC批次主要包含以下具体信息:

1. SDS-PAGE

2. 蛋白质含量

3. 内毒素水平

4. 残留宿主细胞DNA含量

5. 残留宿主细胞蛋白质含量

6. 生物活性分析

7. 微生物检测

8. 支原体检测

9. 体外病毒测定

10. 残留水分

11. 批次间一致性

ACRO产品声明

ACROBiosystems GMP级产品专为研究、生产或离体使用而设计。注意:不可直接供人体使用。

GMP FGF-8b;FGF-8b;FGF-8b蛋白;ACRO;百普赛斯;

公司简介

百普赛斯集团ACROBiosystems Group(股票代码:301080)是成立于2010年的跨国生物科技公司,是为全球生物医药、健康产业领域提供关键生物试剂产品及解决方案的行业平台型基石企业。2021年在创业板上市。百普赛斯集团业务遍布全球,横跨亚洲、北美洲、欧洲,在中国、美国、瑞士等12个城市设有办公室、研发中心及生产基地。目前累计服务客户超6000家,与全球Top 20医药企业均建立了长期、稳定的合作伙伴关系。集团旗下拥有品牌ACROBiosystems百普赛斯、bioSeedin柏思荟、Condense Capital垦拓资本和ACRODiagnostics百斯医学等。

成立日期 (16年)
注册资本 8000万人民币
员工人数 500人以上
年营业额 ¥ 1亿以上
经营模式 工厂,试剂
主营行业 医药中间体,原料药,激素类,氨基糖苷类,中枢神经系统用药

GMP FGF-8b蛋白相关厂家报价

内容声明
拨打电话 立即询价